Cancer Center Member Lawrence E. Feldman, MD, discusses the phase 3 LEAP-006 trial evaluating lenvatinib and pembrolizumab plus chemotherapy in non–small cell lung cancer.
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.